𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glucose metabolism as the site of the primary abnormality in early-onset dementia of Alzheimer type?

✍ Scribed by S. Hoyer; K. Oesterreich; O. Wagner


Publisher
Springer
Year
1988
Tongue
English
Weight
647 KB
Volume
235
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

✦ Synopsis


Global cerebral blood flow, oxidative brain metabolism, and the cerebral arteriovenous differences of amino acids and ammonia were studied in 20 clinically diagnosed patients with early-onset dementia of Alzheimer type (DAT). Eleven healthy age-matched subjects and 15 healthy young volunteers served as controls. The most prominent abnormality in patients with early-onset DAT was a 44% reduction in the cerebral metabolic rate of glucose and a fourfold increase of lactate production, whereas cerebral blood flow and the cerebral metabolic rate of oxygen were found not to be altered. The cerebral amino-N balance substantially changed in patients with early-onset DAT, showing a massive loss of amino acids and ammonia from the brain, which was indicative of excess protein catabolism due to cell degeneration in the acutely diseased brain. The abnormality found in glucose metabolism may suggest a perturbed control of glycolytic breakdown of glucose and its first oxidation step at the pyruvate dehydrogenase complex level, this thus being of pivotal significance in early-onset DAT.


πŸ“œ SIMILAR VOLUMES


Oxiracetam in the treatment of primary d
✍ Stephen R. Dager; J. Pierre Loebel; Keith Claypool; Mary Case; Christopher B. Bu πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 602 KB

## Abstract A 16‐week open‐label trial of high‐dose oxiracetam (up to 3200 mg per day), was not clinically effective overall in treating a small cohort of patients with mild‐moderate dementia of the Alzheimer's type (DAT). However, one of six patients did demonstrate evidence of progressive clinica